ATE109006T1 - Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen. - Google Patents

Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.

Info

Publication number: ATE109006T1
Authority: AT; Austria
Prior art keywords: pharmaceutical composition; treat; composition intended; retroviral infections; arg
Prior art date: 1989-12-18

Application number

AT91901458T

Other languages

English (en)

Inventor

Bruno Guy

Jean-Pierre Lecocq

Original Assignee

Transgene Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-12-18

Filing date

1990-12-18

Publication date

1994-08-15

1990-10-23 Priority claimed from FR9013102A external-priority patent/FR2668065B1/fr

1990-12-18 Application filed by Transgene Sa filed Critical Transgene Sa

1994-08-15 Application granted granted Critical

1994-08-15 Publication of ATE109006T1 publication Critical patent/ATE109006T1/de

Links

239000008194 pharmaceutical composition Substances 0.000 title abstract 2
206010038997 Retroviral infections Diseases 0.000 title 1
LTLYEAJONXGNFG-DCAQKATOSA-N E64 Chemical compound NC(=N)NCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O LTLYEAJONXGNFG-DCAQKATOSA-N 0.000 abstract 2
239000002852 cysteine proteinase inhibitor Substances 0.000 abstract 2
GDBQQVLCIARPGH-UHFFFAOYSA-N Leupeptin Natural products CC(C)CC(NC(C)=O)C(=O)NC(CC(C)C)C(=O)NC(C=O)CCCN=C(N)N GDBQQVLCIARPGH-UHFFFAOYSA-N 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
PGLTVOMIXTUURA-UHFFFAOYSA-N iodoacetamide Chemical compound NC(=O)CI PGLTVOMIXTUURA-UHFFFAOYSA-N 0.000 abstract 1
JDNTWHVOXJZDSN-UHFFFAOYSA-N iodoacetic acid Chemical compound OC(=O)CI JDNTWHVOXJZDSN-UHFFFAOYSA-N 0.000 abstract 1
GDBQQVLCIARPGH-ULQDDVLXSA-N leupeptin Chemical compound CC(C)C[C@H](NC(C)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C=O)CCCN=C(N)N GDBQQVLCIARPGH-ULQDDVLXSA-N 0.000 abstract 1
108010052968 leupeptin Proteins 0.000 abstract 1
230000001177 retroviral effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Communicable Diseases (AREA)
Virology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

AT91901458T 1989-12-18 1990-12-18 Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen. ATE109006T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR8916726		1989-12-18
FR9013102A FR2668065B1 (fr)	1990-10-23	1990-10-23	Composition pharmaceutique destinee au traitement et a la prevention des infections retrovirales.

Publications (1)

Publication Number	Publication Date
ATE109006T1 true ATE109006T1 (de)	1994-08-15

Family

ID=26227737

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91901458T ATE109006T1 (de)	1989-12-18	1990-12-18	Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.

Country Status (8)

Country	Link
EP (1)	EP0506769B1 (de)
JP (1)	JPH05502868A (de)
AT (1)	ATE109006T1 (de)
AU (2)	AU6975591A (de)
CA (1)	CA2071972A1 (de)
DE (1)	DE69011130T2 (de)
DK (1)	DK0506769T3 (de)
WO (1)	WO1991008769A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1993015730A1 (en) *	1992-02-07	1993-08-19	The United States Of America, Represented By The Secretary, Department Of Health And Human Services	Use of 5,5'-dithio-bis(2-nitrobenzoic acid) for inhibition of hiv protease
US6071895A (en) *	1992-03-11	2000-06-06	Narhex Limited	Polar-substituted hydrocarbons
MXPA93002392A (es)	1992-03-11	2005-02-04	Narhex Ltd	Derivados amino de hidrocarburos-oxo e hidroxi-substituidos.
JPH07504654A (ja) *	1992-03-11	1995-05-25	ナルヘックス　リミテッド	オキソ及びヒドロキシ置換炭化水素のアミン誘導体
US5888992A (en) *	1992-03-11	1999-03-30	Narhex Limited	Polar substituted hydrocarbons
HU218892B (hu) *	1992-09-09	2000-12-28	Amgen Inc.	SLPI alkalmazása és eljárás retrovírus-fertőzés gátlására szolgáló gyógyászati készítmény előállítására
FR2778851B1 (fr) *	1998-05-19	2002-07-26	Aetsrn	Composition a base d'inhibiteurs de cysteine-proteases pour retarder la senescence, l'autodestruction et l'hemolyse des erythrocytes
WO2005011649A2 (en) *	2003-05-19	2005-02-10	Vanderbilt University	Methods of treating severe acute respiratory syndrome virus infections
US8232240B2 (en)	2005-02-23	2012-07-31	The Brigham And Women's Hospital, Inc.	Inhibitors of enveloped virus infectivity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SI8510058A8 (en) *	1985-01-16	1996-04-30	Inst Jozef Stefan P O	Process for insulation of poultry egg's cystatine from egg-white
EP0269311A3 (de) *	1986-11-17	1990-06-06	Merck & Co. Inc.	Methoden zur Behandlung von Knochenleiden mittels Verabreichung von Cystein-Proteinaseinhibitoren

1990
- 1990-12-18 AU AU69755/91A patent/AU6975591A/en active Granted
- 1990-12-18 AU AU69755/91A patent/AU644621B2/en not_active Ceased
- 1990-12-18 DK DK91901458.9T patent/DK0506769T3/da active
- 1990-12-18 JP JP3501849A patent/JPH05502868A/ja active Pending
- 1990-12-18 EP EP91901458A patent/EP0506769B1/de not_active Expired - Lifetime
- 1990-12-18 AT AT91901458T patent/ATE109006T1/de not_active IP Right Cessation
- 1990-12-18 CA CA002071972A patent/CA2071972A1/fr not_active Abandoned
- 1990-12-18 DE DE69011130T patent/DE69011130T2/de not_active Expired - Fee Related
- 1990-12-18 WO PCT/FR1990/000921 patent/WO1991008769A1/fr not_active Ceased

Also Published As

Publication number	Publication date
AU644621B2 (en)	1993-12-16
JPH05502868A (ja)	1993-05-20
DK0506769T3 (da)	1994-11-28
EP0506769A1 (de)	1992-10-07
WO1991008769A1 (fr)	1991-06-27
CA2071972A1 (fr)	1991-06-19
DE69011130T2 (de)	1995-03-16
DE69011130D1 (de)	1994-09-01
EP0506769B1 (de)	1994-07-27
AU6975591A (en)	1991-07-18

Similar Documents

Publication	Publication Date	Title
MD1507G2 (ro)	2001-04-30	Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
GB2303629B (en)	1998-09-02	Hydroxamic acids and their use as metalloproteinase inhibitors
DE68919358D1 (de)	1994-12-15	Zusammensetzung zur behandlung der schizophrenie.
MX9603520A (es)	1998-01-31	Derivados del acido hidroxamico y acido carboxilico, procesos para su preparacion y su uso.
EP0766674A4 (de)	1997-09-03	Neue hiv-protease-inhibitoren
DE69116380D1 (de)	1996-02-22	Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
BR0014465A (pt)	2002-06-11	1,1'-bifenil-2-carbonamidas 2'-substituìdas, processos para a sua preparação,seu emprego como medicamento bem como os preparados farmacêuticos contendo as mesmas
ES2045182T3 (es)	1994-01-16	Substancias fisiologicamente activas, un proceso para la preparacion de las mismas y composiciones farmaceuticas que las contienen.
ATE179888T1 (de)	1999-05-15	Ophthalmische zubereitung zur behandlung oder prävention von trockenem auge und krankheiten, die dadurch verursacht werden, enthaltend 12- sulfodehydroabietsäure
RU93032613A (ru)	1996-06-20	Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
ATE109006T1 (de)	1994-08-15	Pharmazeutische zusammensetzung bestimmt zur behandlung oder vorbeugung von retroviralen infektionen.
DE3866045D1 (de)	1991-12-12	Arzneimittel zur behandlung von uraemie.
BR8008818A (pt)	1981-06-23	Peptidos farmacologicamente ativos e medicamentos contendo os mesmos
DE69522702D1 (de)	2001-10-18	Eine lagerstabile wässrige lösung zur infusion die einen thrombininhibitor enthält
GB9930768D0 (en)	2000-02-16	Composition
DK325289A (da)	1989-12-30	Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet
DE69010523D1 (de)	1994-08-18	Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen.
ATE5796T1 (de)	1984-01-15	Pharmazeutische zusammensetzung mit gehalt an l- alpha-methyl-3,4-dihydroxyphenylalanin und salicylamid zur behandlung hohen blutdrucks.
DE3772047D1 (de)	1991-09-12	Pyrazin zur behandlung von haemodynamischen und metabolischen krankheiten.
ATE127118T1 (de)	1995-09-15	2-alkyl-3-benzoylbenzofurane zur behandlung von herzarrhythmia.
GT199400048A (es)	1996-01-12	Composicion farmaceutica y proceso para su preparacion
FI965153A0 (fi)	1996-12-20	Metalloproteinaasi-inhibiittorit
PT99238A (pt)	1992-09-30	Processo para a preparacao de composicoes farmaceuticas contendo um inibidor da enzima conversora da angiotensina e um inibidor da actividade do tromboxano a2, utilizadas no tratamento de nefropatias
MX9603241A (es)	1998-02-28	Productos farmaceuticos para curar enfermedades tumorales y procedimiento para su preparacion.
NO883066L (no)	1988-01-20	Nye steroidforbindelser, befruktningshindrende midler inneholdende forbindelsene som aktiv bestanddel og anvendelseav forbindelsene for aa hindre befruktning.

Legal Events

Date	Code	Title	Description
1995-03-15	UEP	Publication of translation of european patent specification
1999-09-15	REN	Ceased due to non-payment of the annual fee